SCHEMBL3736402

SCHEMBL3736402

CC(C)[C@@H](C(=O)OCc1ccccc1)N1C(=O)CCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
PKM P14618 1/20 0.47
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC1A2 P43004 1/20 0.45
ATM Q13315 1/20 0.42
CASP1 P29466 1/20 0.41
IL1RN P18510 1/20 0.41
ERAP2 Q6P179 1/20 0.41
ERAP1 Q9NZ08 1/20 0.41
CTSB P07858 2/20 0.40
LMNA P02545 1/20 0.40
CTSL P07711 1/20 0.40
CTSK P43235 1/20 0.40
ELANE P08246 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1289870 0.94 SLC1A2 (0.50) ALDH1A1PKMCYP3A4CYP2C9CYP2C19
SCHEMBL19388177 0.83 ATM (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL7407155 0.81 APOBEC3A (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL21960352 0.77 CTSB (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL21960350 0.77 CTSB (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL11338112 0.77 ALDH1A1 (0.62) ALDH1A1PKMCYP3A4CYP2C9CYP2C19
SCHEMBL25924384 0.76 ATM (0.39) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL1399080 0.75 SLC15A1 (0.47) ALDH1A1PKMCYP3A4CYP2C9CYP2C19
SCHEMBL13536560 0.74 CYP3A4 (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19ATM
SCHEMBL939536 0.74 ALDH1A1 (0.64) ALDH1A1ATMCTSBLMNACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102573845-A Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof SHIRE LLC 2012-07-11 CN disclosed
US-20100286186-A1 NOVEL DICARBOXYLIC ACID LINKED AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF SHIRE LLC (US) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286186-A1 NOVEL DICARBOXYLIC ACID LINKED AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF VIP, OPRL1, OPRK1 ALDH1A1 1313/4885PKM 868/4885CYP3A4 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.